Literature DB >> 31173305

The impact of the age range of young healthy reference population on the cut-off points for low muscle mass necessary for the diagnosis of sarcopenia.

R Krzymińska-Siemaszko1, A Fryzowicz, N Czepulis, A Kaluźniak-Szymanowska, L B Dworak, K Wieczorowska-Tobis.   

Abstract

OBJECTIVE: According to the consensus report published by the European Working Group on Sarcopenia in Older People (EWGSOP), sarcopenia researchers should determine sex-specific cut-off points (COPs) for low muscle mass (LMM) in their respective countries. To this end, it is necessary to investigate young healthy adults' group (YHAG). As the EWGSOP hasn't specified any inclusion criteria for this group, there is a significant divergence in literature regarding the age range characterizing YHAG. Therefore, the primary aim of our study was to assess the impact of different YHAG age ranges on the calculated values of COPs for LMM. The secondary aims were to use the calculated COPs for evaluating the prevalence of sarcopenia among the older people from Poland.
MATERIALS AND METHODS: 1512 young healthy individuals were divided into six age subgroups: 20-30, 18-40, 18-39, 20-39, 20-40, and 20-35 years. The sex-specific COPs for LMM were calculated using the Appendicular Lean Mass index. The prevalence of sarcopenia was assessed in 468 older adults from Poland.
RESULTS: In the six age subgroups, six different COPs were obtained in the group of young women (ranging from 5.51 kg/m2 to 5.60 kg/m2), and three different COPs were found in the group of young men (ranging from 7.35 kg/m2 to 7.40 kg/m2). After applying the determined COPs, the overall prevalence of sarcopenia was found to range between 4.5% and 5.1%.
CONCLUSIONS: Since there are no guidelines establishing the YHAG age range, if multiple sex-specific COPs are obtained, the highest values should be applied in the diagnostic of sarcopenia to avoid the misclassification of patients with this disease.

Entities:  

Mesh:

Year:  2019        PMID: 31173305     DOI: 10.26355/eurrev_201905_17938

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  12 in total

1.  Comparison of Diagnostic Performance of SARC-F and Its Two Modified Versions (SARC-CalF and SARC-F+EBM) in Community-Dwelling Older Adults from Poland.

Authors:  Roma Krzymińska-Siemaszko; Ewa Deskur-Śmielecka; Aleksandra Kaluźniak-Szymanowska; Marta Lewandowicz; Katarzyna Wieczorowska-Tobis
Journal:  Clin Interv Aging       Date:  2020-04-28       Impact factor: 4.458

2.  Comparison of four sarcopenia screening questionnaires in community-dwelling older adults from Poland using six sets of international diagnostic criteria of sarcopenia.

Authors:  Roma Krzymińska-Siemaszko; Sławomir Tobis; Marta Lewandowicz; Katarzyna Wieczorowska-Tobis
Journal:  PLoS One       Date:  2020-04-20       Impact factor: 3.240

3.  Predicting the risk of sarcopenia in elderly patients with patellar fracture: development and assessment of a new predictive nomogram.

Authors:  Yi-Sheng Chen; Yan-Xian Cai; Xue-Ran Kang; Zi-Hui Zhou; Xin Qi; Chen-Ting Ying; Yun-Peng Zhang; Jie Tao
Journal:  PeerJ       Date:  2020-04-15       Impact factor: 2.984

4.  Polish version of SARC-F to assess sarcopenia in older adults: An examination of reliability and validity.

Authors:  Roma Krzymińska-Siemaszko; Ewa Deskur-Śmielecka; Aleksandra Kaluźniak-Szymanowska; Arkadiusz Styszyński; Katarzyna Wieczorowska-Tobis
Journal:  PLoS One       Date:  2020-12-21       Impact factor: 3.240

5.  Malnutrition, Sarcopenia, and Malnutrition-Sarcopenia Syndrome in Older Adults with COPD.

Authors:  Aleksandra Kaluźniak-Szymanowska; Roma Krzymińska-Siemaszko; Ewa Deskur-Śmielecka; Marta Lewandowicz; Beata Kaczmarek; Katarzyna Wieczorowska-Tobis
Journal:  Nutrients       Date:  2021-12-23       Impact factor: 5.717

6.  The Effect of a Mixed Circuit of Aerobic and Resistance Training on Body Composition in Older Adults-Retrospective Study.

Authors:  Anna Pieczyńska; Ewa Zasadzka; Tomasz Trzmiel; Małgorzata Pyda; Mariola Pawlaczyk
Journal:  Int J Environ Res Public Health       Date:  2021-05-24       Impact factor: 3.390

7.  The Prevalence of Sarcopenia in Bipolar Disorder.

Authors:  Feridun Bulbul; Irfan Koca; Lut Tamam; Mehmet Emin Demirkol; Soner Cakmak; Emre Ersahinoglu
Journal:  Neuropsychiatr Dis Treat       Date:  2020-04-08       Impact factor: 2.570

Review 8.  Reference Values for Skeletal Muscle Mass - Current Concepts and Methodological Considerations.

Authors:  Carina O Walowski; Wiebke Braun; Michael J Maisch; Björn Jensen; Sven Peine; Kristina Norman; Manfred J Müller; Anja Bosy-Westphal
Journal:  Nutrients       Date:  2020-03-12       Impact factor: 5.717

9.  Polish Translation and Validation of the Mini Sarcopenia Risk Assessment (MSRA) Questionnaire to Assess Nutritional and Non-Nutritional Risk Factors of Sarcopenia in Older Adults.

Authors:  Roma Krzymińska-Siemaszko; Ewa Deskur-Śmielecka; Arkadiusz Styszyński; Katarzyna Wieczorowska-Tobis
Journal:  Nutrients       Date:  2021-03-24       Impact factor: 5.717

10.  Diagnostic Performance and Accuracy of the MNA-SF against GLIM Criteria in Community-Dwelling Older Adults from Poland.

Authors:  Aleksandra Kaluźniak-Szymanowska; Roma Krzymińska-Siemaszko; Marta Lewandowicz; Ewa Deskur-Śmielecka; Katarzyna Stachnik; Katarzyna Wieczorowska-Tobis
Journal:  Nutrients       Date:  2021-06-24       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.